Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
